| Filed | Form | Description | |
|---|---|---|---|
| 5/16/24 | DEFA14A | DEFA14A | → |
| 5/3/24 | DEFA14A | DEFA14A | → |
| 4/22/24 | DEFA14A | DEFA14A | → |
| 4/15/24 | DEFM14A | DEFM14A | → |
| 4/3/24 | PREM14A | PREM14A | → |
| 2/6/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| 12/18/24 | 4 | 4 | → |
| ↓ | |||
It operates as an privately held independent subsidiary of Novo Holdings A/S. It is a provider of drug delivery technologies, drug development, drug manufacturing, biologics, gene therapy, and consumer health products.